ACOG technology assessment. Genetics and molecular diagnostic testing. Number 1, July 2002. American College of Obstetrics and Gynecology (Q40616036)

22 September 2017

title

ACOG technology assessment. Genetics and molecular diagnostic testing. Number 1, July 2002. American College of Obstetrics and Gynecology (English)

1 reference

22 September 2017

author name string

American College of Obstetrics and Gynecology

series ordinal

1

1 reference

22 September 2017

publication date

1 October 2002

1 reference

International Journal of Gynecology and Obstetrics

22 September 2017

published in

1 reference

22 September 2017

volume

79

1 reference

22 September 2017

issue

1

1 reference

22 September 2017

page(s)

67-85

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7292%2802%2980002-9

22 September 2017

1 reference

Risk factors for pre-eclampsia in a large cohort of Latin American and Caribbean women

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7292%2802%2980002-9

A molecular variant of angiotensinogen associated with preeclampsia

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7292%2802%2980002-9

Human cytotrophoblasts adopt a vascular phenotype as they differentiate. A strategy for successful endovascular invasion?

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7292%2802%2980002-9

Preeclampsia is associated with abnormal expression of adhesion molecules by invasive cytotrophoblasts

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7292%2802%2980002-9

Preeclampsia-associated hepatic hemorrhage and rupture: mode of management related to maternal and perinatal outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7292%2802%2980002-9

Pregnancies complicated by HELLP syndrome (hemolysis, elevated liver enzymes, and low platelets): subsequent pregnancy outcome and long-term prognosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7292%2802%2980002-9

Hepatic imaging in HELLP syndrome (hemolysis, elevated liver enzymes, and low platelet count).

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7292%2802%2980002-9

Maternal mortality associated with HELLP (hemolysis, elevated liver enzymes, and low platelets) syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7292%2802%2980002-9

Eclampsia. VIII. Risk factors for maternal morbidity

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7292%2802%2980002-9

Clinicopathological study of neurological complications due to hypertensive disorders of pregnancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7292%2802%2980002-9

Blindness associated with preeclampsia and eclampsia

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7292%2802%2980002-9

Can antenatal clinical and biochemical markers predict the development of severe preeclampsia?

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7292%2802%2980002-9

The clinical utility of serum uric acid measurements in hypertensive diseases of pregnancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7292%2802%2980002-9

Hypertension in pregnancy: diagnosis and treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7292%2802%2980002-9

A comparison of magnesium sulfate with phenytoin for the prevention of eclampsia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7292%2802%2980002-9

Treatment of hypertension in pregnant women

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7292%2802%2980002-9

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7292%2802%2980002-9

The safety and utility of pulmonary artery catheterization in severe preeclampsia and eclampsia

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7292%2802%2980002-9

Preeclampsia prevention: lessons from the low-dose aspirin therapy trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7292%2802%2980002-9

Does gestational hypertension become pre-eclampsia?

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7292%2802%2980002-9

Evaluation of a definition of pre-eclampsia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7292%2802%2980002-9

Should the definition of preeclampsia include a rise in diastolic blood pressure of >/=15 mm Hg to a level <90 mm Hg in association with proteinuria?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7292%2802%2980002-9

Genetics of hypertension in pregnancy: possible single gene control of pre-eclampsia and eclampsia in the descendants of eclamptic women

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7292%2802%2980002-9

Angiotensinogen Thr235 variant is associated with abnormal physiologic change of the uterine spiral arteries in first-trimester decidua

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7292%2802%2980002-9

Correlation between placental bed biopsy findings, vascular cell adhesion molecule and fibronectin levels in pre-eclampsia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7292%2802%2980002-9

The Parkland Memorial Hospital protocol for treatment of eclampsia: evaluation of 245 cases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7292%2802%2980002-9

Longitudinal evaluation of hemodynamic changes in eclampsia.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7292%2802%2980002-9

Hepatic hemorrhage without rupture in preeclampsia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7292%2802%2980002-9

Maternal morbidity and mortality in 442 pregnancies with hemolysis, elevated liver enzymes, and low platelets (HELLP syndrome)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7292%2802%2980002-9

The recurrence risk of the syndrome of hemolysis, elevated liver enzymes, and low platelets (HELLP) in subsequent gestations

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7292%2802%2980002-9

Prediction of pre-eclampsia, low birthweight for gestation and prematurity by uterine artery blood flow velocity waveforms analysis in low risk nulliparous women.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7292%2802%2980002-9

A protocol for managing severe preeclampsia in the second trimester

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7292%2802%2980002-9

Aggressive versus expectant management of severe preeclampsia at 28 to 32 weeks' gestation: a randomized controlled trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7292%2802%2980002-9

Severe preeclampsia remote from term: labor induction or elective cesarean delivery?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7292%2802%2980002-9

Antihypertensive therapy in pregnancy directed by noninvasive hemodynamic monitoring

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7292%2802%2980002-9

Prevention of preeclampsia: a big disappointment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7292%2802%2980002-9

Trial of Calcium to Prevent Preeclampsia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7292%2802%2980002-9

Effect of antioxidants on the occurrence of pre-eclampsia in women at increased risk: a randomised trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7292%2802%2980002-9

A randomised controlled trial of intravenous magnesium sulphate versus placebo in the management of women with severe pre-eclampsia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7292%2802%2980002-9

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/S0020-7292(02)80002-9

1 reference

22 September 2017

1 reference